RISK FACTOR, CARDIOVASCULAR
Clinical trials for RISK FACTOR, CARDIOVASCULAR explained in plain language.
Never miss a new study
Get alerted when new RISK FACTOR, CARDIOVASCULAR trials appear
Sign up with your email to follow new studies for RISK FACTOR, CARDIOVASCULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart shield for chemo: carvedilol may protect breast cancer Patients' hearts
Disease control CompletedThis early-phase study tested whether the heart medication carvedilol could safely protect breast cancer patients from heart damage caused by chemotherapy drugs like doxorubicin and trastuzumab. 68 women with early-stage breast cancer were assigned to either receive carvedilol or…
Matched conditions: RISK FACTOR, CARDIOVASCULAR
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Heart risks during CAR T-Cell therapy under the microscope
Knowledge-focused CompletedThis study followed 44 adults with leukemia or lymphoma who received CAR T-cell therapy to see how their hearts were affected. Researchers used heart scans, blood tests, and quality-of-life surveys before and after treatment. The goal was to learn how often heart problems occur a…
Matched conditions: RISK FACTOR, CARDIOVASCULAR
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC